| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Amgen is experiencing robust growth in product/service development driven by a strong commitment to innovation and successful drug trials. The recent landmark results for Repatha and significant sales growth indicate a positive trajectory in their cardiovascular therapy offerings. Additionally, the progress on experimental drugs like MariTide highlights the company's ongoing efforts to enhance its product portfolio. However, the operational costs associated with developing these new therapies pose a challenge that needs to be managed carefully. |
| The price action of Amgen (AMGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.2 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for AMGN since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.4, and the negative at -0.2 on 2025-11-04. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (2.3) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| AMGN | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-04 | 0%(0%) | 0 | 0% | 0.2 | 2.3 | 7 | |||||||
| 2025-11-03 | 0%(0%) | 0 | 0% | -0.1 | 0.6 | -1 | |||||||
| 2025-11-02 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-11-01 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-10-31 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-10-30 | 0%(0%) | 0 | 0% | -0.3 | -1 | -1 | |||||||
| 2025-10-29 | 0%(0%) | 0 | 0% | -0.6 | -2.6 | -1 | |||||||
| 2025-10-28 | 0%(0%) | 0 | 0% | -0.8 | -3.8 | -1 | |||||||
| 2025-10-27 | 0%(0%) | 0 | 0% | -0.7 | -3.4 | -1 | |||||||
| 2025-10-26 | 0%(0%) | 0 | 0% | -0.6 | -2.5 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-04 17:49:14 The article mentions hurdles from Washington and the risks of increased competition, highlighting potential market challenges. |
| 2025-11-04 17:49:14 Amgen's drug sales beat expectations, showcasing strong product performance and development outcomes. |
| 2025-11-04 17:49:14 The article discusses Amgen's raised guidance after exceeding third-quarter earnings expectations, indicating confidence in financial performance. |
| 2025-11-04 17:09:18 The higher operating expenses and tax rates point to challenges that could affect Amgen's future profitability. |
| 2025-11-04 17:09:18 A slight increase in the stock price indicates positive market sentiment and investor confidence in Amgen's stability and growth. |
| 2025-11-04 17:09:18 The ongoing development of Amgen's weight-loss drug MariTide is a pivotal aspect for future revenue, showing potential impact despite current operational costs. |
| 2025-11-04 17:09:18 The increase in product sales by 12% is a significant indicator of Amgen's market performance and product acceptance. |
| 2025-11-04 17:09:18 Amgen's recent financial results exceeded market expectations, highlighting a positive trajectory in revenue and earnings. |